WO1999026926A1 - Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors - Google Patents
Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors Download PDFInfo
- Publication number
- WO1999026926A1 WO1999026926A1 PCT/US1998/025185 US9825185W WO9926926A1 WO 1999026926 A1 WO1999026926 A1 WO 1999026926A1 US 9825185 W US9825185 W US 9825185W WO 9926926 A1 WO9926926 A1 WO 9926926A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methyl
- amino
- alkyl
- compound
- pyridinone
- Prior art date
Links
- 0 *C(CC1)CCC1N Chemical compound *C(CC1)CCC1N 0.000 description 9
- SLRKEIXZGBSCQJ-UHFFFAOYSA-N CC(N(CC(NCCCONC(N)=N)=O)C1=O)=CC=C1NS(c1ncccc1)(=O)=O Chemical compound CC(N(CC(NCCCONC(N)=N)=O)C1=O)=CC=C1NS(c1ncccc1)(=O)=O SLRKEIXZGBSCQJ-UHFFFAOYSA-N 0.000 description 1
- PJPOOKGPJPVZHT-UHFFFAOYSA-N CC(N(CC(NCCONC(N)=N)=O)C1=O)=CC=C1NS(Cc(c(F)ccc1)c1Cl)(=O)=O Chemical compound CC(N(CC(NCCONC(N)=N)=O)C1=O)=CC=C1NS(Cc(c(F)ccc1)c1Cl)(=O)=O PJPOOKGPJPVZHT-UHFFFAOYSA-N 0.000 description 1
- KXJNOJVWOFONHL-UHFFFAOYSA-N CC(N(CC(NCCONC(N)=N)=O)C1=O)=CC=C1NS(c(cc1)ccc1Br)(P)=O Chemical compound CC(N(CC(NCCONC(N)=N)=O)C1=O)=CC=C1NS(c(cc1)ccc1Br)(P)=O KXJNOJVWOFONHL-UHFFFAOYSA-N 0.000 description 1
- RNTJFVMEYGHAFO-UHFFFAOYSA-N CC(N(CC(NCCONC(N)=N)=O)C1=O)=CC=C1NS(c(cccc1)c1OC(F)(F)F)(=O)=O Chemical compound CC(N(CC(NCCONC(N)=N)=O)C1=O)=CC=C1NS(c(cccc1)c1OC(F)(F)F)(=O)=O RNTJFVMEYGHAFO-UHFFFAOYSA-N 0.000 description 1
- CSBIFMMBICHMPO-UHFFFAOYSA-N CC(N(CC(NCCONC(N)=N)=O)C1=O)=CC=C1NS(c1cc(C(F)(F)F)ccc1)(P)=O Chemical compound CC(N(CC(NCCONC(N)=N)=O)C1=O)=CC=C1NS(c1cc(C(F)(F)F)ccc1)(P)=O CSBIFMMBICHMPO-UHFFFAOYSA-N 0.000 description 1
- FGGULDFMSVLXOV-UHFFFAOYSA-N CCCc(cc1)ccc1S(NC1=CC=C(C)N(CC(NCCONC(N)=N)=O)C1=O)(=O)=O Chemical compound CCCc(cc1)ccc1S(NC1=CC=C(C)N(CC(NCCONC(N)=N)=O)C1=O)(=O)=O FGGULDFMSVLXOV-UHFFFAOYSA-N 0.000 description 1
- QOXZERWOHGZMIM-UHFFFAOYSA-N Cc(cc1)ccc1S(NC1=CC=C(C)N(CC(NCCONC(N)=N)=O)C1=O)(P)=O Chemical compound Cc(cc1)ccc1S(NC1=CC=C(C)N(CC(NCCONC(N)=N)=O)C1=O)(P)=O QOXZERWOHGZMIM-UHFFFAOYSA-N 0.000 description 1
- VIBPFYJDXXIUSI-KHPPLWFESA-N Cc1c(/C=C\[IH]C=C)c(S(NC2=CC=C(C)N(CC(NCCONC(N)=N)=O)C2=O)(=O)=O)ccc1 Chemical compound Cc1c(/C=C\[IH]C=C)c(S(NC2=CC=C(C)N(CC(NCCONC(N)=N)=O)C2=O)(=O)=O)ccc1 VIBPFYJDXXIUSI-KHPPLWFESA-N 0.000 description 1
- DPJTUTYEOHPYDD-UHFFFAOYSA-N Cc1c(CS(NC2=CC=C(C)N(CC(NCCONC(N)=N)=O)C2=O)(=O)=O)cccc1 Chemical compound Cc1c(CS(NC2=CC=C(C)N(CC(NCCONC(N)=N)=O)C2=O)(=O)=O)cccc1 DPJTUTYEOHPYDD-UHFFFAOYSA-N 0.000 description 1
- ULUMQKWPALDYFF-UHFFFAOYSA-N Cc1ccc(C(F)(F)F)cc1S(NC1=CC=C(C)N(CC(NCCONC(N)=N)=O)C1=O)(=O)=O Chemical compound Cc1ccc(C(F)(F)F)cc1S(NC1=CC=C(C)N(CC(NCCONC(N)=N)=O)C1=O)(=O)=O ULUMQKWPALDYFF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9815325-0A BR9815325A (pt) | 1997-11-26 | 1998-11-25 | Heteroaril, aminoguanidinas e alcóxiguanidinas eseu uso como inibidores da protease |
EP98962838A EP1036063B1 (en) | 1997-11-26 | 1998-11-25 | Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
CA002311969A CA2311969A1 (en) | 1997-11-26 | 1998-11-25 | Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
DE69836346T DE69836346T2 (de) | 1997-11-26 | 1998-11-25 | Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer |
JP2000522084A JP2001524467A (ja) | 1997-11-26 | 1998-11-25 | ヘテロアリールアミノグアニジンおよびアルコキシグアニジンおよびプロテアーゼインヒビターとしてのこれらの使用 |
AU17991/99A AU751412B2 (en) | 1997-11-26 | 1998-11-25 | Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
EA200000578A EA004180B1 (ru) | 1997-11-26 | 1998-11-25 | Гетероарильные производные аминогуанидинов и алкоксигуанидинов (варианты), способ их получения и их применение в качестве ингибиторов протеаз |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6647597P | 1997-11-26 | 1997-11-26 | |
US6732497P | 1997-12-05 | 1997-12-05 | |
US7910798P | 1998-03-23 | 1998-03-23 | |
US60/066,475 | 1998-03-23 | ||
US60/079,107 | 1998-03-23 | ||
US60/067,324 | 1998-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999026926A1 true WO1999026926A1 (en) | 1999-06-03 |
Family
ID=27370979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/025185 WO1999026926A1 (en) | 1997-11-26 | 1998-11-25 | Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
Country Status (14)
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999064446A1 (en) * | 1998-06-11 | 1999-12-16 | 3-Dimensional Pharmaceuticals, Inc. | Pyrazinone protease inhibitors |
WO2001004117A1 (en) * | 1999-07-09 | 2001-01-18 | 3-Dimensional Pharmaceuticals, Inc. | Heteroaryl protease inhibitors and diagnostic imaging agents |
WO2001087852A1 (en) * | 2000-05-18 | 2001-11-22 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
WO2002012193A1 (en) * | 2000-08-07 | 2002-02-14 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
WO2002012207A1 (en) * | 2000-08-04 | 2002-02-14 | 3-Dimensional Pharmaceuticals, Inc. | Cyclic oxyguanidine protease inhibitors |
WO2002028825A2 (en) * | 2000-10-06 | 2002-04-11 | 3-Dimensional Pharmaceuticals, Inc. | Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
US6476016B2 (en) | 2000-07-17 | 2002-11-05 | 3-Dimensional Pharmaceuticals, Inc. | Cyclic oxyguanidine pyrazinones as protease inhibitors |
US6486174B2 (en) | 2000-08-07 | 2002-11-26 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
WO2003007984A1 (de) * | 2001-07-16 | 2003-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von thrombin-inhibitoren zur behandlung von arthritis |
US6624180B2 (en) | 2000-11-20 | 2003-09-23 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
US6653316B1 (en) | 1999-05-19 | 2003-11-25 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
US6660885B2 (en) | 2000-03-13 | 2003-12-09 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
US6664255B1 (en) | 1999-05-19 | 2003-12-16 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
US6686484B2 (en) | 2000-04-17 | 2004-02-03 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
US6693121B2 (en) | 2000-04-05 | 2004-02-17 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
US6716838B1 (en) | 1999-05-19 | 2004-04-06 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
US6750342B1 (en) | 1999-05-19 | 2004-06-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
WO2004091613A2 (en) * | 2003-04-10 | 2004-10-28 | 3-Dimensional Pharmaceuticals, Inc. | Substituted phenyl acetamides and their use as protease inhibitors |
US6867217B1 (en) | 1999-05-19 | 2005-03-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
US6875791B2 (en) | 2000-04-05 | 2005-04-05 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
WO2005110988A1 (en) * | 2004-05-07 | 2005-11-24 | Janssen Pharmaceutica, N.V. | Pyridone compounds as inhibitors of bacterial type iii protein secretion systems |
US6969715B2 (en) | 2001-10-03 | 2005-11-29 | Pharmacia Corporation | 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
US7015230B1 (en) | 1999-05-19 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
US7015223B1 (en) | 2000-11-20 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
US7105559B2 (en) | 2001-10-03 | 2006-09-12 | Pharmacia Corporation | Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
US7119094B1 (en) | 2000-11-20 | 2006-10-10 | Warner-Lambert Company | Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade |
US7262211B2 (en) | 2001-12-04 | 2007-08-28 | Dendreon Corporation | Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation |
US8518934B2 (en) | 2008-06-11 | 2013-08-27 | Shonogi & Co., Ltd. | Oxycarbamoyl compounds and the use thereof |
US8563732B2 (en) | 2007-05-31 | 2013-10-22 | Shionogi & Co., Ltd. | Oxyimino compounds and the use thereof |
EP2982668A2 (en) | 2002-12-03 | 2016-02-10 | Pharmacyclics LLC | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors for the treatment of thromboembolic disorders |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI222441B (en) * | 1997-11-26 | 2004-10-21 | Dimensional Pharm Inc | Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
NZ508005A (en) * | 1998-04-24 | 2003-05-30 | Dimensional Pharm Inc | Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines useful as serine protease inhibitors |
US6908919B2 (en) * | 1999-05-19 | 2005-06-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
US6906068B1 (en) | 1999-05-19 | 2005-06-14 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants |
PL352403A1 (en) * | 1999-05-19 | 2003-08-25 | Pharmacia Corp | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of coagulation cascade |
AU5046600A (en) | 1999-05-27 | 2000-12-18 | 3-Dimensional Pharmaceuticals, Inc. | Oxazaheterocycles as protease inhibitors |
JP2003509409A (ja) | 1999-09-13 | 2003-03-11 | 3−ディメンショナル ファーマシューティカルズ, インコーポレイテッド | アザシクロアルカノンセリンプロテアーゼ阻害剤 |
EP1127884A1 (en) * | 2000-02-26 | 2001-08-29 | Aventis Pharma Deutschland GmbH | Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them |
AU2001217827A1 (en) * | 2000-05-18 | 2001-11-26 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
US20030236257A1 (en) * | 2001-04-04 | 2003-12-25 | South Michael S. | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the cogulation cascade |
JP2005514332A (ja) * | 2001-10-03 | 2005-05-19 | ファルマシア・コーポレーション | 凝固カスケードの選択阻害に有用な6員不飽和複素環式化合物 |
US20040082585A1 (en) * | 2001-10-03 | 2004-04-29 | Pharmacia Corporation | Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
US7553810B2 (en) * | 2004-06-16 | 2009-06-30 | Pneumrx, Inc. | Lung volume reduction using glue composition |
US20050281799A1 (en) | 2004-06-16 | 2005-12-22 | Glen Gong | Targeting damaged lung tissue using compositions |
US7678767B2 (en) | 2004-06-16 | 2010-03-16 | Pneumrx, Inc. | Glue compositions for lung volume reduction |
US7608579B2 (en) * | 2004-06-16 | 2009-10-27 | Pneumrx, Inc. | Lung volume reduction using glue compositions |
US20050281798A1 (en) * | 2004-06-16 | 2005-12-22 | Glen Gong | Targeting sites of damaged lung tissue using composition |
US20050281739A1 (en) * | 2004-06-16 | 2005-12-22 | Glen Gong | Imaging damaged lung tissue using compositions |
US20050281740A1 (en) * | 2004-06-16 | 2005-12-22 | Glen Gong | Imaging damaged lung tissue |
EP1781182B1 (en) | 2004-07-08 | 2019-11-13 | PneumRx, Inc. | Pleural effusion treatment device |
US20070255177A1 (en) * | 2006-04-27 | 2007-11-01 | Pronovost Allan D | Devices and methods for collecting oral samples of enriched serous fluid |
US7758001B2 (en) * | 2006-09-13 | 2010-07-20 | Premier Mounts | Mount with magnetic attachment and automatic safety latching |
US20100297218A1 (en) * | 2006-09-20 | 2010-11-25 | Pneumrx, Inc. | Tissue adhesive compositions and methods thereof |
EP2177523A1 (en) | 2007-05-03 | 2010-04-21 | Intermune, Inc. | Novel macrocyclic inhibitors of hepatitis c virus replication |
WO2010134345A1 (ja) * | 2009-05-20 | 2010-11-25 | 積水メディカル株式会社 | 血液凝固時間延長剤 |
US8349832B2 (en) * | 2009-09-02 | 2013-01-08 | Canthera Therapeutics | Compounds and compositions for treating cancer |
US8318737B2 (en) | 2009-09-02 | 2012-11-27 | Canthera Therapeutics Inc. | Compounds and compositions for treating cancer |
AU2011349022B2 (en) | 2010-12-21 | 2017-04-13 | The Medicines Company (Leipzig) Gmbh | Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa |
CN104857005B (zh) | 2010-12-31 | 2019-04-26 | 阿斯利康公司 | 精氨酸酶抑制剂及其使用方法 |
CA2835434A1 (en) | 2011-05-17 | 2012-11-22 | Velico Medical, Inc. | Improved platelet storage using a sialidase inhibitor |
US9788539B2 (en) | 2011-05-17 | 2017-10-17 | Velico Medical, Inc. | Platelet protection solution having beta-galactosidase and sialidase inhibitors |
WO2014055988A1 (en) | 2012-10-05 | 2014-04-10 | Velico Medical, Inc. | Platelet additive solution having a beta-galactosidase inhibitor |
WO2014120886A1 (en) | 2013-01-30 | 2014-08-07 | Velico Medical, Inc. | Platelet additive solution having a self-assembling hydrogel-forming peptide |
US20150365084A1 (en) * | 2014-06-13 | 2015-12-17 | Infineon Technologies Austria Ag | Circuits and methods for operating a circuit |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996018644A1 (en) * | 1994-12-13 | 1996-06-20 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
WO1997001338A1 (en) * | 1995-06-27 | 1997-01-16 | Merck & Co., Inc. | Pyridinone-thrombin inhibitors |
WO1997030708A1 (en) * | 1996-02-22 | 1997-08-28 | Merck & Co., Inc. | Pyridinone thrombin inhibitors |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4097472A (en) | 1974-11-08 | 1978-06-27 | Mitsubishi Chemical Industries Limited | N2 -arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof |
SU328634A1 (ru) | 1971-01-05 | 1978-01-05 | Butyrin V G | Устройство дл забора проб крови у животных |
SU938739A3 (ru) | 1977-01-19 | 1982-06-23 | Мицубиси Кемикал Индастриз Лимитед(Фирма) | Способ получени N -арилсульфонил-L-аргининамидов или их солей |
US4418052A (en) * | 1980-08-12 | 1983-11-29 | Wong Dennis W | Diagnostic compositions and method for radiologic imaging of fibrinogen deposition in the body |
US4980148A (en) * | 1985-02-06 | 1990-12-25 | Mallinckrodt, Inc. | Methods for enhancing magnetic resonance imaging |
US5011686A (en) * | 1987-09-21 | 1991-04-30 | Creative Biomolecules, Inc. | Thrombus specific conjugates |
ZA897515B (en) * | 1988-10-07 | 1990-06-27 | Merrell Dow Pharma | Novel peptidase inhibitors |
US5024829A (en) * | 1988-11-21 | 1991-06-18 | Centocor, Inc. | Method of imaging coronary thrombi |
US5656600A (en) * | 1993-03-25 | 1997-08-12 | Corvas International, Inc. | α-ketoamide derivatives as inhibitors of thrombosis |
US5658885A (en) * | 1993-04-27 | 1997-08-19 | The Dupont Merck Pharmaceutical Company | Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
GB9318637D0 (en) | 1993-09-08 | 1993-10-27 | Ferring Res Ltd | Enzyme inhibitors |
US5466811A (en) * | 1994-07-18 | 1995-11-14 | Merck & Co., Inc. | Dioxolenylmethyl carbamates pro moieties for amine drugs |
US5658930A (en) * | 1994-12-13 | 1997-08-19 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
US5656645A (en) * | 1994-12-13 | 1997-08-12 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
ATE341317T1 (de) | 1996-03-29 | 2006-10-15 | Ortho Mcneil Pharm Inc | Amidinohydrazone als protease-inhibitoren |
TW499412B (en) | 1996-11-26 | 2002-08-21 | Dimensional Pharm Inc | Aminoguanidines and alkoxyguanidines as protease inhibitors |
TWI222441B (en) * | 1997-11-26 | 2004-10-21 | Dimensional Pharm Inc | Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
ATE461210T1 (de) * | 1998-06-11 | 2010-04-15 | Ortho Mcneil Pharm Inc | Pyrazine protease inhibitore |
AU5046600A (en) | 1999-05-27 | 2000-12-18 | 3-Dimensional Pharmaceuticals, Inc. | Oxazaheterocycles as protease inhibitors |
WO2001004117A1 (en) | 1999-07-09 | 2001-01-18 | 3-Dimensional Pharmaceuticals, Inc. | Heteroaryl protease inhibitors and diagnostic imaging agents |
US6236492B1 (en) * | 1999-08-03 | 2001-05-22 | Crystal Corporation | Electrode with a balanced centroid, soft edges and an apodization ratio greater than one |
-
1998
- 1998-11-25 TW TW087119488A patent/TWI222441B/zh not_active IP Right Cessation
- 1998-11-25 ES ES98962838T patent/ES2274587T3/es not_active Expired - Lifetime
- 1998-11-25 WO PCT/US1998/025185 patent/WO1999026926A1/en active IP Right Grant
- 1998-11-25 DE DE69836346T patent/DE69836346T2/de not_active Expired - Fee Related
- 1998-11-25 JP JP2000522084A patent/JP2001524467A/ja active Pending
- 1998-11-25 AT AT98962838T patent/ATE344246T1/de not_active IP Right Cessation
- 1998-11-25 CA CA002311969A patent/CA2311969A1/en not_active Abandoned
- 1998-11-25 EA EA200000578A patent/EA004180B1/ru not_active IP Right Cessation
- 1998-11-25 US US09/199,167 patent/US6037356A/en not_active Expired - Lifetime
- 1998-11-25 PL PL98340560A patent/PL340560A1/xx not_active Application Discontinuation
- 1998-11-25 AU AU17991/99A patent/AU751412B2/en not_active Ceased
- 1998-11-25 EP EP98962838A patent/EP1036063B1/en not_active Expired - Lifetime
- 1998-11-25 BR BR9815325-0A patent/BR9815325A/pt not_active Application Discontinuation
- 1998-11-26 AR ARP980106006A patent/AR016702A1/es unknown
-
2000
- 2000-01-14 US US09/482,540 patent/US6245763B1/en not_active Expired - Lifetime
-
2001
- 2001-04-06 US US09/827,292 patent/US6350764B2/en not_active Expired - Lifetime
- 2001-12-12 US US10/012,445 patent/US6472399B2/en not_active Expired - Lifetime
-
2002
- 2002-09-12 US US10/241,513 patent/US6566379B1/en not_active Expired - Lifetime
-
2003
- 2003-03-27 US US10/400,073 patent/US6706021B2/en not_active Expired - Lifetime
- 2003-11-17 US US10/714,988 patent/US7029654B2/en not_active Expired - Lifetime
-
2005
- 2005-10-19 US US11/254,086 patent/US7402586B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996018644A1 (en) * | 1994-12-13 | 1996-06-20 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
WO1997001338A1 (en) * | 1995-06-27 | 1997-01-16 | Merck & Co., Inc. | Pyridinone-thrombin inhibitors |
WO1997030708A1 (en) * | 1996-02-22 | 1997-08-28 | Merck & Co., Inc. | Pyridinone thrombin inhibitors |
Cited By (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999064446A1 (en) * | 1998-06-11 | 1999-12-16 | 3-Dimensional Pharmaceuticals, Inc. | Pyrazinone protease inhibitors |
EP1589029A3 (en) * | 1998-06-11 | 2006-01-18 | Johnson & Johnson Pharmaceutical Research & Development L.L.C. | Pyrazinone protease inhibitors |
US7015230B1 (en) | 1999-05-19 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
US6867217B1 (en) | 1999-05-19 | 2005-03-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
US6653316B1 (en) | 1999-05-19 | 2003-11-25 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
US6750342B1 (en) | 1999-05-19 | 2004-06-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
US6664255B1 (en) | 1999-05-19 | 2003-12-16 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
US6716838B1 (en) | 1999-05-19 | 2004-04-06 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
US6458952B1 (en) | 1999-05-19 | 2002-10-01 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
US6870056B1 (en) | 1999-05-19 | 2005-03-22 | Pharmacia Corporation | Substitituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
US6420397B1 (en) | 1999-07-09 | 2002-07-16 | 3-Dimensional Pharmaceuticals, Inc. | Heteroaryl protease inhibitors and diagnostic imaging agents |
WO2001004117A1 (en) * | 1999-07-09 | 2001-01-18 | 3-Dimensional Pharmaceuticals, Inc. | Heteroaryl protease inhibitors and diagnostic imaging agents |
US6852761B2 (en) | 2000-03-13 | 2005-02-08 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
US6660885B2 (en) | 2000-03-13 | 2003-12-09 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
US6875791B2 (en) | 2000-04-05 | 2005-04-05 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
US6916847B2 (en) | 2000-04-05 | 2005-07-12 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
US6693121B2 (en) | 2000-04-05 | 2004-02-17 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
US6686484B2 (en) | 2000-04-17 | 2004-02-03 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
WO2001087852A1 (en) * | 2000-05-18 | 2001-11-22 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
US6476016B2 (en) | 2000-07-17 | 2002-11-05 | 3-Dimensional Pharmaceuticals, Inc. | Cyclic oxyguanidine pyrazinones as protease inhibitors |
US7030110B2 (en) | 2000-07-17 | 2006-04-18 | Ortho-Mcneil Pharmaceuticals, Inc. | Cyclic oxyguanidine pyrazinones as protease inhibitors |
WO2002012207A1 (en) * | 2000-08-04 | 2002-02-14 | 3-Dimensional Pharmaceuticals, Inc. | Cyclic oxyguanidine protease inhibitors |
US6635637B2 (en) | 2000-08-04 | 2003-10-21 | Dimensional Pharmaceuticals, Inc. | Cyclic oxyguanidine protease inhibitors |
US6486174B2 (en) | 2000-08-07 | 2002-11-26 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
WO2002012193A1 (en) * | 2000-08-07 | 2002-02-14 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
US6900231B2 (en) | 2000-10-06 | 2005-05-31 | 3-Dimensional Pharmaceuticals, Inc. | Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
CN1315803C (zh) * | 2000-10-06 | 2007-05-16 | 三维药物公司 | 作为蛋白酶抑制剂的氨基吡啶基-,氨基胍基-和烷氧基胍基-取代苯基乙酰胺 |
WO2002028825A3 (en) * | 2000-10-06 | 2002-06-13 | Dimensional Pharm Inc | Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
WO2002028825A2 (en) * | 2000-10-06 | 2002-04-11 | 3-Dimensional Pharmaceuticals, Inc. | Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
US6828338B2 (en) | 2000-11-20 | 2004-12-07 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
US7119094B1 (en) | 2000-11-20 | 2006-10-10 | Warner-Lambert Company | Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade |
US7015223B1 (en) | 2000-11-20 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
US6624180B2 (en) | 2000-11-20 | 2003-09-23 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
WO2003007984A1 (de) * | 2001-07-16 | 2003-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von thrombin-inhibitoren zur behandlung von arthritis |
US6969715B2 (en) | 2001-10-03 | 2005-11-29 | Pharmacia Corporation | 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
US7105559B2 (en) | 2001-10-03 | 2006-09-12 | Pharmacia Corporation | Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
US7262211B2 (en) | 2001-12-04 | 2007-08-28 | Dendreon Corporation | Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation |
EP2982668A2 (en) | 2002-12-03 | 2016-02-10 | Pharmacyclics LLC | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors for the treatment of thromboembolic disorders |
WO2004091613A2 (en) * | 2003-04-10 | 2004-10-28 | 3-Dimensional Pharmaceuticals, Inc. | Substituted phenyl acetamides and their use as protease inhibitors |
US7550474B2 (en) | 2003-04-10 | 2009-06-23 | Johnson & Johnson Pharmaceuticals Research & Development, L.L.C. | Substituted phenyl acetamides and their use as protease inhibitors |
WO2004091613A3 (en) * | 2003-04-10 | 2005-01-27 | Dimensional Pharm Inc | Substituted phenyl acetamides and their use as protease inhibitors |
US7087622B2 (en) | 2004-05-07 | 2006-08-08 | Janssen Pharmaceutica N.V. | Pyridone compounds as inhibitors of bacterial type III protein secreation systems |
WO2005110988A1 (en) * | 2004-05-07 | 2005-11-24 | Janssen Pharmaceutica, N.V. | Pyridone compounds as inhibitors of bacterial type iii protein secretion systems |
US8563732B2 (en) | 2007-05-31 | 2013-10-22 | Shionogi & Co., Ltd. | Oxyimino compounds and the use thereof |
US8518934B2 (en) | 2008-06-11 | 2013-08-27 | Shonogi & Co., Ltd. | Oxycarbamoyl compounds and the use thereof |
Also Published As
Publication number | Publication date |
---|---|
AR016702A1 (es) | 2001-07-25 |
US6350764B2 (en) | 2002-02-26 |
EA004180B1 (ru) | 2004-02-26 |
US7402586B2 (en) | 2008-07-22 |
US20040106633A1 (en) | 2004-06-03 |
CA2311969A1 (en) | 1999-06-03 |
BR9815325A (pt) | 2001-12-26 |
US6566379B1 (en) | 2003-05-20 |
DE69836346T2 (de) | 2007-05-24 |
ATE344246T1 (de) | 2006-11-15 |
AU1799199A (en) | 1999-06-15 |
AU751412B2 (en) | 2002-08-15 |
TWI222441B (en) | 2004-10-21 |
US6037356A (en) | 2000-03-14 |
US6706021B2 (en) | 2004-03-16 |
DE69836346D1 (de) | 2006-12-14 |
US6245763B1 (en) | 2001-06-12 |
EP1036063A1 (en) | 2000-09-20 |
US20030087921A1 (en) | 2003-05-08 |
ES2274587T3 (es) | 2007-05-16 |
US6472399B2 (en) | 2002-10-29 |
EA200000578A1 (ru) | 2001-02-26 |
US20030225115A1 (en) | 2003-12-04 |
EP1036063B1 (en) | 2006-11-02 |
US20020007070A1 (en) | 2002-01-17 |
US20060211719A1 (en) | 2006-09-21 |
JP2001524467A (ja) | 2001-12-04 |
PL340560A1 (en) | 2001-02-12 |
US20020086872A1 (en) | 2002-07-04 |
US7029654B2 (en) | 2006-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6472399B2 (en) | Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors | |
EP1086122B1 (en) | Pyrazinone protease inhibitors | |
WO1999051571A1 (en) | Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors | |
WO2002028825A2 (en) | Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors | |
US6326492B1 (en) | Heterocyclic protease inhibitors | |
US6420397B1 (en) | Heteroaryl protease inhibitors and diagnostic imaging agents | |
CA2384247A1 (en) | Azacycloalkanone serine protease inhibitors | |
WO2004091613A2 (en) | Substituted phenyl acetamides and their use as protease inhibitors | |
MXPA00005055A (en) | Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 98812495.5 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
ENP | Entry into the national phase |
Ref document number: 2000 522084 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2000/005055 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2311969 Country of ref document: CA Ref document number: 2311969 Country of ref document: CA Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 17991/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998962838 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200000578 Country of ref document: EA |
|
WWP | Wipo information: published in national office |
Ref document number: 1998962838 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 17991/99 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 1998962838 Country of ref document: EP |